These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
145 related items for PubMed ID: 1542672
21. In vitro and in vivo evaluation of carboranyl uridines as boron delivery agents for neutron capture therapy. Liu L, Barth RF, Tjarks W, Soloway AH, Anisuzzaman AK. Anticancer Res; 1996; 16(1):113-20. PubMed ID: 8615595 [Abstract] [Full Text] [Related]
22. Synthesis and biological evaluation of new BSH-conjugated chlorin derivatives as agents for both photodynamic therapy and boron neutron capture therapy of cancer. Asano R, Nagami A, Fukumoto Y, Miura K, Yazama F, Ito H, Sakata I, Tai A. J Photochem Photobiol B; 2014 Nov; 140():140-9. PubMed ID: 25123528 [Abstract] [Full Text] [Related]
23. Evaluation of tumour and tissue distribution of porphyrins for use in photodynamic therapy. Woodburn KW, Stylli S, Hill JS, Kaye AH, Reiss JA, Phillips DR. Br J Cancer; 1992 Mar; 65(3):321-8. PubMed ID: 1558783 [Abstract] [Full Text] [Related]
24. Evaluation of pharmacokinetics of 4-borono-2-(18)F-fluoro-L-phenylalanine for boron neutron capture therapy in a glioma-bearing rat model with hyperosmolar blood-brain barrier disruption. Hsieh CH, Chen YF, Chen FD, Hwang JJ, Chen JC, Liu RS, Kai JJ, Chang CW, Wang HE. J Nucl Med; 2005 Nov; 46(11):1858-65. PubMed ID: 16269600 [Abstract] [Full Text] [Related]
26. Boron neutron capture therapy of EGFR or EGFRvIII positive gliomas using either boronated monoclonal antibodies or epidermal growth factor as molecular targeting agents. Yang W, Barth RF, Wu G, Tjarks W, Binns P, Riley K. Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S328-31. PubMed ID: 19467880 [Abstract] [Full Text] [Related]
27. Boron-containing protoporphyrin IX derivatives and their modification for boron neutron capture therapy: synthesis, characterization, and comparative in vitro toxicity evaluation. El-Zaria ME, Ban HS, Nakamura H. Chemistry; 2010 Feb 01; 16(5):1543-52. PubMed ID: 20020518 [Abstract] [Full Text] [Related]
30. L-DOPA preloading increases the uptake of borophenylalanine in C6 glioma rat model: a new strategy to improve BNCT efficacy. Capuani S, Gili T, Bozzali M, Russo S, Porcari P, Cametti C, D'Amore E, Colasanti M, Venturini G, Maraviglia B, Lazzarino G, Pastore FS. Int J Radiat Oncol Biol Phys; 2008 Oct 01; 72(2):562-7. PubMed ID: 18793958 [Abstract] [Full Text] [Related]
31. Synthesis and biological evaluation of boron-containing polyamines as potential agents for neutron capture therapy of brain tumors. Zhuo JC, Cai J, Soloway AH, Barth RF, Adams DM, Ji W, Tjarks W. J Med Chem; 1999 Apr 08; 42(7):1282-92. PubMed ID: 10197971 [Abstract] [Full Text] [Related]
32. Quantitative imaging and microlocalization of boron-10 in brain tumors and infiltrating tumor cells by SIMS ion microscopy: relevance to neutron capture therapy. Smith DR, Chandra S, Barth RF, Yang W, Joel DD, Coderre JA. Cancer Res; 2001 Nov 15; 61(22):8179-87. PubMed ID: 11719448 [Abstract] [Full Text] [Related]
33. In vivo evaluation of phosphorous-containing derivatives of dodecahydro-closo-dodecaborate for boron neutron capture therapy of gliomas and sarcomas. Tjarks W, Barth RF, Rotaru JH, Adams DM, Yang W, Kultyshev RG, Forrester J, Barnum BA, Soloway AH, Shore SG. Anticancer Res; 2001 Nov 15; 21(2A):841-6. PubMed ID: 11396173 [Abstract] [Full Text] [Related]
34. PET pharmacokinetic analysis to estimate boron concentration in tumor and brain as a guide to plan BNCT for malignant cerebral glioma. Nariai T, Ishiwata K, Kimura Y, Inaji M, Momose T, Yamamoto T, Matsumura A, Ishii K, Ohno K. Appl Radiat Isot; 2009 Jul 15; 67(7-8 Suppl):S348-50. PubMed ID: 19375930 [Abstract] [Full Text] [Related]
35. Subcellular distribution of various boron compounds and implications for their efficacy in boron neutron capture therapy by Monte Carlo simulations. Nguyen T, Brownell GL, Holden SA, Kahl S, Miura M, Teicher BA. Radiat Res; 1993 Jan 15; 133(1):33-40. PubMed ID: 8434111 [Abstract] [Full Text] [Related]
36. Positron emission tomography-based boron neutron capture therapy using boronophenylalanine for high-grade gliomas: part I. Imahori Y, Ueda S, Ohmori Y, Sakae K, Kusuki T, Kobayashi T, Takagaki M, Ono K, Ido T, Fujii R. Clin Cancer Res; 1998 Aug 15; 4(8):1825-32. PubMed ID: 9717808 [Abstract] [Full Text] [Related]
37. A Hypoxia-Targeted Boron Neutron Capture Therapy Agent for the Treatment of Glioma. Luderer MJ, Muz B, de la Puente P, Chavalmane S, Kapoor V, Marcelo R, Biswas P, Thotala D, Rogers B, Azab AK. Pharm Res; 2016 Oct 15; 33(10):2530-9. PubMed ID: 27401411 [Abstract] [Full Text] [Related]
38. A carboranyl porphyrin for boron neutron capture therapy of brain tumors. Kahl SB, Joel DD, Finkel GC, Micca PL, Nawrocky MM, Coderre JA, Slatkin DN. Basic Life Sci; 1989 Oct 15; 50():193-203. PubMed ID: 2751608 [No Abstract] [Full Text] [Related]
39. Recent progress in the syntheses and biological evaluation of boronated porphyrins for boron neutron-capture therapy. Renner MW, Miura M, Easson MW, Vicente MG. Anticancer Agents Med Chem; 2006 Mar 15; 6(2):145-57. PubMed ID: 16529537 [Abstract] [Full Text] [Related]